Stanley Druckenmiller: portfolio of Duquesne Family Office

Stanley Druckenmiller manages his own wealth through the Duquesne Family Office; earlier he ran the macro fund Duquesne Capital.

Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2025. Go to the latest filing (Q3 2026)

3.0B USDQ1 2025
Total value of stock positions
3.0B USD
Positions
49
Share of the ten largest
61.4%

The ten largest positions Q1 2025

  1. Natera Inc 16.1%▼ −4.6%
  2. Teva Pharmaceutical Inds Ltd 7.7%▲ +65.4%
  3. Coupang Inc 6.8%▲ +4.5%
  4. Woodward Inc 6.7%▼ −10.4%
  5. Philip Morris International 5.9%▼ −18.3%
  6. Coherent Corp. 4.8%▼ −21.2%
  7. MercadoLibre 3.5%unchanged
  8. Insmed Inc 3.5%▲ +130.7%
  9. Taiwan Semiconductor Manufacturing (ADR) 3.3%▲ +456.9%
  10. Docusign Inc 2.9%new
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 4.5B USD).
Choose a quarter (54 filings)

All positions Q1 2025

Positions Q1 2025 per 13F filing, 49 of 49
Symbol Weight Shares Reported value Change Held since
Natera Inc 16.1% 3,402,330 481.1M USD −4.6% reduced Q3 2022 11 quarters
Teva Pharmaceutical Inds Ltd 7.7% 14,879,750 228.7M USD +65.4% increased Q3 2024 3 quarters
Coupang Inc 6.8% 9,302,634 204.0M USD +4.5% increased Q1 2021 17 quarters
Woodward Inc 6.7% 1,097,750 200.3M USD −10.4% reduced Q4 2023 6 quarters
PM Philip Morris International 5.9% 1,105,268 175.4M USD −18.3% reduced Q2 2024 4 quarters
COHR Coherent Corp. 4.8% 2,222,070 144.3M USD −21.2% reduced Q1 2024 5 quarters
MELI MercadoLibre 3.5% 53,725 104.8M USD unchanged Q2 2024 4 quarters
Insmed Inc 3.5% 1,369,050 104.4M USD +130.7% increased Q2 2024 4 quarters
TSM Taiwan Semiconductor Manufacturing (ADR) 3.3% 598,780 99.4M USD +456.9% increased Q3 2024 3 quarters
Docusign Inc 2.9% 1,074,655 87.5M USD new Q1 2025 1 quarter
Flutter Entmt Plc 2.8% 377,475 83.6M USD +1,985.5% increased Q2 2024 4 quarters
LLY Lilly (Eli) 2.6% 94,830 78.3M USD +52.5% increased Q4 2024 2 quarters
Ypf Sociedad Anonima 2.4% 2,075,390 72.7M USD +23.0% increased Q2 2024 4 quarters
Verona Pharma Plc 2.1% 1,002,080 63.6M USD +12.9% increased Q3 2024 3 quarters
Barclays Plc 2.0% 3,817,305 58.6M USD +19.8% increased Q1 2024 5 quarters
WAB Wabtec 1.8% 301,095 54.6M USD +7.5% increased Q1 2024 5 quarters
Ccc Intelligent Solutions Hl 1.7% 5,595,039 50.5M USD new Q1 2025 1 quarter
KMI Kinder Morgan 1.6% 1,654,115 47.2M USD −25.7% reduced Q1 2024 5 quarters
EQT EQT Corporation 1.5% 859,345 45.9M USD new Q1 2025 1 quarter
Caesars Entertainment Inc Ne 1.3% 1,548,420 38.7M USD new Q1 2025 1 quarter
FCX Freeport-McMoRan 1.3% 1,018,105 38.5M USD +34.2% increased Q4 2023 6 quarters
Daktronics Inc 1.3% 3,067,625 37.4M USD +16.9% increased Q1 2024 5 quarters
Global X Fds 1.2% 443,800 35.8M USD −19.1% reduced Q1 2024 5 quarters
TWLO Twilio 1.2% 362,155 35.5M USD new Q1 2025 1 quarter
COF Capital One 1.2% 197,670 35.4M USD new Q1 2025 1 quarter
Roku Inc 1.2% 493,600 34.8M USD new Q1 2025 1 quarter
Banco Macro Sa 1.1% 431,815 32.6M USD −11.0% reduced Q1 2024 5 quarters
Springworks Therapeutics Inc 0.9% 615,929 27.2M USD −28.4% reduced Q2 2024 4 quarters
AMZN Amazon 0.9% 136,765 26.0M USD −58.4% reduced Q4 2024 2 quarters
UAL United Airlines Holdings 0.9% 368,685 25.5M USD −64.7% reduced Q4 2024 2 quarters
Ascendis Pharma A/S 0.8% 158,720 24.7M USD −40.1% reduced Q3 2024 3 quarters
Purecycle Technologies Inc 0.8% 3,364,842 23.3M USD +111.3% increased Q4 2024 2 quarters
Grupo Financiero Galicia S.A 0.7% 381,481 20.8M USD −15.0% reduced Q1 2024 5 quarters
Seagate Technology Hldngs Pl 0.6% 219,477 18.6M USD −86.0% reduced Q3 2023 7 quarters
Brookfield Corp 0.6% 315,925 16.6M USD −48.2% reduced Q4 2024 2 quarters
Newamsterdam Pharma Company 0.5% 800,360 16.4M USD +178.4% increased Q3 2024 3 quarters
Teck Resources Ltd 0.5% 431,545 15.7M USD unchanged Q1 2022 13 quarters
Bridgebio Pharma Inc 0.5% 438,050 15.1M USD new Q1 2025 1 quarter
DAL Delta Air Lines 0.5% 345,135 15.0M USD −57.8% reduced Q4 2024 2 quarters
FLEX Flex Ltd. 0.4% 348,900 11.5M USD unchanged Q4 2023 6 quarters
EXE Expand Energy 0.4% 97,700 10.9M USD new Q1 2025 1 quarter
APP AppLovin 0.4% 40,200 10.7M USD new Q1 2025 1 quarter
Antero Resources Corp 0.4% 258,400 10.5M USD new Q1 2025 1 quarter
Impinj Inc 0.3% 108,475 9.8M USD new Q1 2025 1 quarter
TSLA Tesla, Inc. 0.2% 18,838 4.9M USD −50.0% reduced Q4 2024 2 quarters
Ultragenyx Pharmaceutical In 0.1% 85,445 3.1M USD unchanged Q3 2024 3 quarters
American Airl < 0.1% 133,728 1.4M USD −85.5% reduced Q4 2024 2 quarters
Invivyd Inc < 0.1% 571,425 346.0K USD unchanged Q2 2024 4 quarters
JOBY Joby Aviation < 0.1% 31,489 190.0K USD unchanged Q3 2022 11 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 3 option positions, value of the underlying shares as reported 77.9M USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • Delta Air Lines Call 41.4M USD
  • Seagate Technology Hldngs Pl Call 20.9M USD
  • United Airlines Holdings Call 15.6M USD

Breakdown by sector

  • Technology 9.7%
  • Consumer Staples 5.9%
  • Energy 3.5%
  • Industrials 3.2%
  • Health Care 2.6%
  • Materials 1.3%
  • Financials 1.2%
  • Consumer Discretionary 1.0%
  • Communication Services 0.4%
  • not in our coverage 71.2%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close